How much weight can you lose on tirzepatide?

In the SURMOUNT-1 trial, a phase 3 double-blind randomized trial published in The New England Journal of Medicine, 2,539 adults with obesity or weight-related complications received tirzepatide or placebo for 72 weeks. Between 85% and 91% of participants receiving tirzepatide achieved a weight reduction of 5% or more. These are trial averages, not a NovaGenix outcome. Individual results vary.

How much does tirzepatide cost at NovaGenix?

NovaGenix is a self-pay practice and does not bill insurance. There is no single program price, because patients need different medications, formulations, strengths, laboratory testing and follow-up. What you pay depends on what Dr. Mackey recommends for you after your evaluation, and your expected cost is explained in full before you begin treatment.

PHYSICIAN-SUPERVISED WEIGHT LOSS IN JUPITER, FL

Compounded Tirzepatide Weight Loss in Jupiter, Florida

Q: How does tirzepatide work?

Tirzepatide is a once-weekly injectable peptide developed from the native GIP sequence, able to stimulate both GIP and GLP-1 receptors. This dual action addresses energy balance by tapping into multiple endogenous nutrient-stimulated hormonal pathways. It belongs to a class of drugs known as incretin mimetics.

Q: What are the side effects of tirzepatide?

Gastrointestinal events are the most commonly reported adverse events, primarily during the initial phase of treatment or during dose escalation: nausea, vomiting, diarrhea and constipation. Other reported effects include hypoglycemia, injection-site reactions such as redness, itching or pain, decreased appetite, and rarely gallbladder-related issues such as cholecystitis or cholelithiasis. Allergic reactions are uncommon but possible. Side effects vary from person to person.

Q: How do I get tirzepatide at NovaGenix?

You start with a consultation at the Jupiter office, or by telehealth if you are an eligible patient in Florida. Every patient is seen by Timothy Mackey, D.O. He reviews your medical history, current medications and existing health conditions. Laboratory testing is decided case by case and is most useful when an underlying cause such as a thyroid or hormone disorder may be contributing. If tirzepatide is appropriate, he discusses dosing, expected results, side effects and monitoring. NovaGenix does not prescribe on the basis of an online form.

A physician-directed approach to dual-pathway weight management—built around a real medical evaluation, individualized dosing, and ongoing follow-up.

Medically reviewed by Timothy Mackey, D.O., Medical Director
Florida License OS9185 · Last reviewed August 31, 2026

Request a consultation Call 561-277-8260

A consultation does not guarantee a prescription. Eligible Florida patients may be seen by telemedicine.

Timothy Mackey, D.O., Medical Director of NovaGenix Health & Wellness

Timothy Mackey, D.O.Medical Director · Physician-led evaluation and monitoring

★★★★★4.9 Google Rating

A+BBB Rating

PHYSICIANIndividual evaluation

FLORIDALicense OS9185

MONITORINGOngoing follow-up

START HERE

Quick answers about tirzepatide

Clear, medically grounded information before you decide whether a consultation makes sense.

What is it?

Tirzepatide is the active ingredient in Zepbound and Mounjaro.

How does it work?

It acts on two incretin pathways—GIP and GLP-1—involved in appetite and metabolic regulation.

How is it given?

Tirzepatide is administered as a once-weekly subcutaneous injection with gradual dose adjustments.

What did the trial show?

In SURMOUNT-1, 85% to 91% of participants receiving tirzepatide achieved at least 5% weight reduction at 72 weeks. Results vary.

Is telehealth available?

Eligible patients throughout Florida may be seen by telemedicine when clinically appropriate.

Is a prescription guaranteed?

No. Treatment is prescribed only after a physician evaluation confirms it is appropriate.

THE MEDICATION

What is tirzepatide?

Tirzepatide is the active ingredient in Zepbound, approved for chronic weight management in appropriate patients, and Mounjaro, approved for type 2 diabetes. NovaGenix prescribes compounded tirzepatide, which is prepared by a licensed compounding pharmacy and is not an FDA-approved finished drug product. NovaGenix does not prescribe branded Zepbound or Mounjaro.

Tirzepatide is one treatment option within medical weight loss in Jupiter, FL. Your clinician can explain which options fit your history and goals.

Treatment is prescribed and monitored after a medical evaluation and review of your medications and health history.

Zepbound and compounded tirzepatide: what’s the difference?

Zepbound is a brand name; tirzepatide is the medication ingredient. Mounjaro also contains tirzepatide, but the branded products have different approved uses and instructions.

What NovaGenix offers: NovaGenix works with compounding pharmacies for compounded tirzepatide following an individualized medical evaluation. We do not prescribe branded Zepbound or Mounjaro.

What patients should understand: Compounded tirzepatide is not Zepbound or an FDA-approved generic. Compounded drugs are not reviewed by FDA for safety, effectiveness or quality before marketing. Equal effectiveness to the branded product should not be assumed.

FDA recommends compounded drugs only when a patient’s medical needs cannot be met by an FDA-approved drug. Your clinician should explain the exact formulation, why it is being considered and the follow-up plan. Read FDA’s explanation of compounded GLP-1 medicines.

Compare semaglutide and tirzepatide · Explore the NovaGenix medical weight-loss program in Jupiter · Request a consultation

CANDIDACY

Who may be a candidate?

Eligibility is based on more than a number on the scale. Medical history, current medications, goals, risks, and alternatives all matter.

MAY BE CONSIDERED

Common starting criteria

Adults with a BMI greater than 30
Adults with a BMI greater than 27 plus a weight-related medical condition
Patients prepared to pair medication with nutrition, movement, and follow-up

REQUIRES MEDICAL REVIEW

Individual risk factors

A physician should review your health history, medications, prior weight-loss treatment, and potential contraindications before any decision is made.

Review important safety information →

THE NOVAGENIX PROCESS

What treatment actually looks like

Tirzepatide is a prescription medication—not a program you join by completing an online questionnaire.

Physician evaluation

Meet with Timothy Mackey, D.O., in Jupiter or by eligible Florida telehealth to review history, medications, and goals.

Testing when indicated

Laboratory testing is ordered case by case when an underlying thyroid, hormone, or metabolic issue may be relevant.

Individual treatment plan

If appropriate, dosing, expectations, potential side effects, and monitoring are discussed before treatment begins.

Ongoing monitoring

Follow-up tracks progress, adjusts treatment where appropriate, and addresses side effects early.

Protecting lean muscle is part of the plan.Protein intake, resistance training, hydration, and an appropriate rate of weight loss should be discussed from the start.Read the NovaGenix guide →

Semaglutide vs. tirzepatide injections

This overview compares the FDA-approved weight-management injections. The products, doses and eligibility criteria differ; they should not be combined or substituted without the prescribing clinician’s direction.

Key differences between the two prescription injections
Feature	Semaglutide	Tirzepatide
Receptor activity	GLP-1 receptor agonist	GIP and GLP-1 receptor agonist
Injection schedule	Once weekly, with gradual dose escalation	Once weekly, with gradual dose escalation
Weight-management brand	Wegovy injection	Zepbound injection
Treatment goal	Weight reduction and long-term maintenance with nutrition and physical activity	Weight reduction and long-term maintenance with nutrition and physical activity
Common side effects	Nausea, vomiting, diarrhea and constipation	Nausea, vomiting, diarrhea and constipation

Individual weight loss varies. Your physician considers your medical history, current medications, tolerability and treatment goals. Both products carry important warnings and are contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2. This table is not a complete safety summary.

Compounded products are not FDA-approved and are not the branded products compared here. Confirm the exact formulation and treatment plan with your clinician.

Sources: Wegovy prescribing information; Zepbound prescribing information; FDA information on compounded GLP-1 medicines.

IMPORTANT SAFETY INFORMATION

Tirzepatide has real benefits—and real risks

Common side effects include nausea, vomiting, diarrhea, constipation, decreased appetite, and abdominal discomfort. These are most likely when treatment begins or the dose is increased.

Anything severe or persistent should be reported promptly rather than waiting for the next scheduled visit.

TREATMENT OPTIONS

Tirzepatide or semaglutide?

Both are once-weekly injectable medications used for weight management, but they act on different pathways.

For a detailed comparison, read our semaglutide vs. tirzepatide guide.

Patients may also ask about other medications discussed in the news. NovaGenix provides a separate educational overview of retatrutide and weight loss.

GLP-1 + GIP

Tirzepatide

Acts on both GLP-1 and GIP receptors. The appropriate choice depends on medical history, other medications, tolerability, cost, and availability.

GLP-1

Semaglutide

Acts on the GLP-1 receptor. The choice is made during consultation—not before your medical evaluation.

Semaglutide for weight loss →

COST

Transparent self-pay care

NovaGenix is a self-pay practice and does not bill insurance. The compounded tirzepatide program is $299 per month, including all physician consultations, follow-up appointments, medication, common injection supplies and shipping. Ask about any separately billed, clinically indicated lab work.

Your expected cost is explained before treatment begins. Call or text 561-277-8260.

JUPITER

Local care, statewide access

NovaGenix is located at 609 North Hepburn Ave, Suite 106, Jupiter, FL 33458. Patients visit from Palm Beach Gardens, Tequesta, Juno Beach, North Palm Beach, Stuart, and Port St. Lucie.

Telehealth is available to eligible patients elsewhere in Florida.

NovaGenix: $299 per month with physician-led care

Our compounded tirzepatide program includes all physician consultations, follow-up appointments, medication, common injection supplies and shipping. Ask whether clinically indicated lab work carries a separate charge.

Compare with Zepbound self-pay medication prices

2.5 mg: $299 — the same advertised amount as NovaGenix’s monthly package; 2.5 mg is a starting dose.
5 mg: $399 — $100 above NovaGenix’s monthly package.
7.5, 10, 12.5 and 15 mg: $449 with the qualifying refill program — $150 above NovaGenix’s monthly package. Refill within 45 days to retain this offer.
Without the timely-refill offer: $499 for 7.5 mg and $699 for 10, 12.5 or 15 mg under current terms.

Eligible patients with commercial insurance covering Zepbound may pay as little as $25 with Lilly’s savings card. Restrictions apply; insured costs may be lower than NovaGenix’s package.

What about Mounjaro?

Lilly lists Mounjaro at $1,112.16 per fill before discounts. NovaGenix’s $299 monthly package is $813.16 below that undiscounted reference amount. Actual pharmacy costs vary. Mounjaro is a diabetes medication; its savings card requires an approved-use prescription and eligible commercial insurance. With coverage, patients may pay as little as $25 for a qualifying fill; eligible commercially insured patients without Mounjaro coverage may pay as low as $499 for a one-month fill. Government-insured patients are excluded from that card. Lilly also directs patients to self-pay options.

Medication price versus a care package

NovaGenix includes physician consultations and follow-up appointments, as well as medication, common supplies and shipping. The branded prices above are pharmacy medication offers, not a package of ongoing physician visits. Prescriber visits and follow-up costs depend on the provider and insurance.

LillyDirect advertises free delivery for Zepbound; shipping should not be counted as an extra charge in that comparison. Injection supplies for its KwikPen and vial must be purchased separately. Supplies and delivery arrangements for other presentations or pharmacies vary.

Lilly generally defines a month as a 28-day supply; NovaGenix quotes its program per month. Compare supply duration, eligibility, lab charges and total care costs. These are price comparisons, not dose-equivalence or equal-effectiveness claims. Compounded tirzepatide is not FDA-approved or an FDA-approved generic of Zepbound or Mounjaro. NovaGenix does not prescribe those brands; treatment requires an individualized evaluation.

Checked September 28, 2026; offers may change. Sources: LillyDirect Zepbound prices and supply information · Zepbound savings terms · Mounjaro list price · Mounjaro savings eligibility.

Ask about NovaGenix’s $299 monthly tirzepatide program · Explore the overall weight-loss program.

COMMON QUESTIONS

Frequently asked questions

Is the tirzepatide prescribed at NovaGenix FDA-approved?

Tirzepatide is the active ingredient in FDA-approved Zepbound and Mounjaro. NovaGenix prescribes compounded tirzepatide, which is prepared by a licensed compounding pharmacy and is not an FDA-approved finished drug product.

Do I need lab work before starting?

Not always. Testing is decided case by case, based on your history and the treatment being considered. What does not vary is the physician evaluation.

Can my consultation be done by telehealth?

Consultations may be conducted in person in Jupiter or by telehealth when clinically appropriate. Telehealth is available to eligible Florida patients.

How is tirzepatide different from semaglutide?

Tirzepatide acts on GIP and GLP-1 receptors, while semaglutide acts on GLP-1 alone. Which medication may be appropriate depends on your health history, current medications, tolerability, cost, and availability.

PHYSICIAN-LED CARE

Start with a consultation in Jupiter

Timothy Mackey, D.O., reviews your health history and medications, discusses whether tirzepatide may be appropriate, and monitors treatment throughout.

Request a consultation Call 561-277-8260

What is tirzepatide?

Medically reviewed by Timothy Mackey, D.O., Medical Director, NovaGenix. Last reviewed: August 31, 2026.

The quest to combat obesity has long been an uphill battle, with health complications and mortality rates rising globally. A groundbreaking study, the SURMOUNT-1 trial, delved into uncharted territory, exploring the effectiveness and safety of tirzepatide, a novel treatment, in individuals grappling with obesity.

Mounjaro's main ingredient, Tirzepatide and its role in losing weight

Tirzepatide may be better known by most people as its brand name, Mounjaro. Originally developed to treat diabetes, it has gained fame as of late for its ability to help shed pounds. Recently, the U.S. Food and Drug Administration granted approval for obesity treatment to a drug known as Zepbound. This medication contains the active ingredient tirzepatide. Originally marketed as Mounjaro for diabetes management by EliLilly and Co., it's now authorized under the name Zepbound for weight management.

This approval extends its use to assist individuals dealing with obesity or overweight conditions, particularly those with related health issues such as high blood pressure or other similar chronic conditions. ABCNews reported that last month, a study was conducted and showed that tirzepatide helped some patients who were overweight or obese lose about a quarter of their body weight. When coupled with diet and exercise the results were more dramatic. The results also suggested that it could be more effective than Semaglutide.

Why obesity is difficult to treat

Obesity is a metabolic condition, not a willpower problem

Obesity's grasp extends far beyond physical weight; its repercussions stretch into various health domains, from cardiovascular diseases to type 2 diabetes. Traditional approaches focused on lifestyle modifications, but the complexity of obesity revealed a deeper, multifaceted metabolic condition, urging a shift in treatment strategies.

How does tirzepatide work?

Enter tirzepatide - a once-weekly injectable peptide developed from the native GIP sequence, armed with the ability to stimulate both GIP and GLP-1 receptors. This dual action aimed to address energy balance by tapping into multiple endogenous nutrient-stimulated hormonal pathways. Tirzepatide is a medication that belongs to a class of drugs known as incretin mimetics. It's a novel, once-weekly injectable drug that works as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Its mechanism of action involves several key aspects:

GLP-1 Receptor Agonism: Tirzepatide activates the GLP-1 receptor, a hormone that stimulates the release of insulin from the pancreas in response to elevated blood sugar levels. This process helps to regulate blood sugar levels after meals.
GIP Receptor Agonism: GIP is another hormone involved in the regulation of insulin release in response to food intake. Tirzepatide also acts on GIP receptors, further enhancing insulin secretion and reducing blood sugar levels.
Appetite Regulation: GLP-1 agonists have been associated with reducing appetite and promoting a feeling of fullness, leading to decreased food intake. This effect can contribute to weight loss in individuals with obesity. The combined action on both GLP-1 and GIP receptors allows tirzepatide to address both blood sugar regulation and weight management in people with type 2 diabetes and obesity. By enhancing insulin release and reducing appetite, tirzepatide can help lower blood sugar levels, promoteweight loss, and improve various metabolic parameters. Its effectiveness in reducing body weight and improving metabolic outcomes has been demonstrated in clinical trials, making tirzepatide a promising medication for managing both diabetes and obesity.

The SURMOUNT-1 Trial: A Deep Dive Into Tirzepatide for Weight-Loss

How the SURMOUNT-1 trial was designed

In this phase 3 double-blind, randomized trial, published in The New England Journal of Medicine, 2539 adults with obesity, or those with weight-related complications, were enrolled. The participants were assigned to receive tirzepatide at varying doses or a placebo for 72 weeks.

What the SURMOUNT-1 trial found

The findings were groundbreaking: participants receiving tirzepatide showcased substantial weight reductions compared to the placebo group. The percentages were staggering: 85% to 91% of individuals on tirzepatide achieved weight reduction of 5% or more, a threshold known for its positive metabolic impacts. Moreover, higher weight-loss targets of 10% or more, 15% or more, and even 20% or more were achieved by a majority of participants across the tirzepatide groups.

Health improvements beyond weight loss

Tirzepatide not only helped shed pounds but also exhibited positive effects on various cardiometabolic risk factors. Improved waist circumference, blood pressure, insulin levels, and lipid profiles were notable among those on tirzepatide, potentially reducing the risk of cardiovascular diseases and type2 diabetes.

Some of the associated benefits discovered during clinical trials included:

1.Weight Loss: One of the most significant benefits of tirzepatide is its ability to induce substantial weight loss. Clinical trials have demonstrated remarkable reductions in body weight in individuals with obesity. It's been observed to be more effective than some other medications used for weight management. Recently, Wegovy has become a popular weight loss medication and its suggested that trizepatide may be even more effective.

2.Improved Glycemic Control: Tirzepatide has shown efficacy in reducing blood sugar levels in individuals with type 2 diabetes. It helps in controlling glucose levels by stimulating the release of insulin and suppressing glucagon, a hormone that raises blood sugar levels.

3. Metabolic Health Improvements: Apart from weight loss and glycemic control, tirzepatide has been associated with improvements in other metabolic parameters, such as reduced waist circumference, improved blood pressure, lipid levels, and increased insulin sensitivity.

4.Reduction in Cardiovascular Risk Factors: Clinical data suggests that tirzepatide may contribute to reducing the risk factors associated with cardiovascular diseases, including hypertension and dyslipidemia.

5. Potential Prevention of Diabetes Development: In individuals with prediabetes, tirzepatide has shown the ability to prevent the progression to type 2 diabetes. It promotes a shift from prediabetes to normoglycemia. These benefits can significantly impact the overall health and well-being of individuals with obesity and/or type 2 diabetes, potentially reducing the risk of associated complications and improving overall quality of life. However, it's important to consider these benefits in the context of individual health conditions and consult a healthcare professional to determine if tirzepatide is an appropriate treatment option.

What are the side effects of tirzepatide?

Safety was paramount, and tirzepatide showed a profile consistent with previous trials. Gastrointestinal events were the most commonly reported adverse events, primarily during the initial phase.

1. Gastrointestinal Issues: Nausea, vomiting, diarrhea, and constipation are among the most common side effects reported. These symptoms often occur at the beginning of treatment or during dose escalation and may diminish over time.

2. Hypoglycemia: Since tirzepatide worksto lower blood sugar levels, there's a risk of hypoglycemia (low blood sugar). This risk is higher when combined with other medications that lower blood sugar or in individuals with poor food intake.

3. Injection-Site Reactions: Redness, itching, or pain at the injection site may occur.

4. Decreased Appetite: Some people may experience a reduced appetite or a feeling of fullness, which can lead to decreased food intake.

5. Potential Gallbladder-related Issues:Rarely, there have been reports of cholecystitis (inflammation of the gallbladder) or cholelithiasis (gallstones). These events are more commonly observed in individuals undergoing substantial weight loss, which is a potential side effect of this medication.

6. Allergic Reactions: Although uncommon,allergic reactions such as rash, itching, or swelling might occur. Severe allergic reactions are rare but possible. It's important to note that the side effects experienced can vary from person to person. Some individuals may not experience any side effects, while others might have a few or several. If you're considering tirzepatide or any new medication, it's crucial to discuss potential side effects and risks with your healthcare provider. They can provide personalized guidance based on your health history and help manage any side effects that may arise during treatment.

Where tirzepatide fits in obesity treatment

The implications of these findings are profound. Tirzepatide demonstrated unprecedented weight reduction, rivaling even some surgical interventions. Moreover, it showcased potential benefits in improving overall body composition, presenting a promising tool in the medical management of obesity.

Who should not use tirzepatide or semaglutide?

Semaglutide and tirzepatide are not appropriate for everyone. These medications are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or a known serious hypersensitivity to the medication or its ingredients.

These medications also carry important warnings and precautions. Before treatment, patients should tell their healthcare provider about any history of pancreatitis, gallbladder disease, kidney problems, severe gastrointestinal disease or gastroparesis, diabetes or diabetic retinopathy, or previous serious reactions to GLP-1–based medications. Patients taking insulin or certain other diabetes medications may have an increased risk of hypoglycemia.

Semaglutide and tirzepatide used for weight management should be discontinued if pregnancy occurs. Patients who are pregnant, planning pregnancy, or breastfeeding should discuss this with their healthcare provider before treatment.

A medical evaluation and review of medications and health history are necessary to determine whether treatment is appropriate for an individual patient.

How Much Does Tirzepatide Cost?

NovaGenix is a self-pay practice and does not bill insurance. In practice that removes the parts of this process patients find worst: there is no prior authorization to chase, no insurance denial to appeal and no pharmacy back-and-forth. It also means the cost of treatment is paid directly.

Your expected cost is explained in full before you begin treatment, so you can decide whether to proceed. Call or text 561-277-8260 to ask about pricing for your situation.

How do I get tirzepatide at NovaGenix?

You start with a consultation at our Jupiter office, or by telehealth if you are an eligible patient in Florida. Call or text 561-277-8260 to schedule. NovaGenix does not prescribe tirzepatide on the basis of an online form.

Here is what the process looks like:

1. Schedule your consultation. Call or text NovaGenix at 561-277-8260. The team will explain what to bring and book your appointment.

2. Evaluation with Dr. Mackey. Every patient is seen by Timothy Mackey, D.O. — not a nurse practitioner or physician assistant. He reviews your medical history, your current medications and any existing health conditions.

3. Laboratory testing when it is needed. Labs are decided case by case rather than ordered automatically. They are most useful when an underlying cause such as a thyroid or hormone disorder may be contributing to your weight, and Dr. Mackey will tell you whether testing is warranted in your case.

4. Your treatment plan. If tirzepatide is appropriate, Dr. Mackey discusses dosing, what results to expect, side effects and what monitoring will involve. NovaGenix prescribes compounded tirzepatide, which is prepared by a licensed compounding pharmacy and is not an FDA-approved product.

5. Ongoing monitoring. Regular follow-up to track your progress, adjust dosing where appropriate and manage side effects, including protecting lean muscle during weight loss.

Start with a consultation in Jupiter

The SURMOUNT-1 trial heralds a new era in combating obesity, offering hope to millions worldwide. While the trial highlighted remarkable outcomes, further studies will unravel tirzepatide's full potential and its role in transforming obesity management. Losing weight brings a spectrum of health advantages that go beyond just shedding pounds. Beyond the obvious aesthetic changes, weight loss can significantly improve overall health.

It reduces the risk of chronic diseases like heart disease, type 2 diabetes, and hypertension. It enhances mobility, reducing joint pain and improving physical endurance. Weight loss also boosts mental health, fostering confidence and reducing stress. Moreover, it often leads to better sleep patterns and increased energy levels. Embracing a healthier weight isn't just about appearance; it's a gateway to a more vibrant, energetic, and fulfilling life.

Every patient at NovaGenix is seen by Timothy Mackey, D.O. Call or text 561-277-8260 to schedule a consultation in Jupiter, or to ask whether tirzepatide is an option for you.

Contact Us

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Compounded Tirzepatide Weight Loss in Jupiter, Florida

Quick answers about tirzepatide

What is it?

How does it work?

How is it given?

What did the trial show?

Is telehealth available?

Is a prescription guaranteed?

What is tirzepatide?

Zepbound and compounded tirzepatide: what’s the difference?

Who may be a candidate?

Common starting criteria

Individual risk factors

What treatment actually looks like

Physician evaluation

Testing when indicated

Individual treatment plan

Ongoing monitoring

Semaglutide vs. tirzepatide injections

Tirzepatide has real benefits—and real risks

Tirzepatide or semaglutide?

Tirzepatide

Semaglutide

Transparent self-pay care

Local care, statewide access

NovaGenix: $299 per month with physician-led care

Compare with Zepbound self-pay medication prices

What about Mounjaro?

Medication price versus a care package

Frequently asked questions

Start with a consultation in Jupiter

Tirzepatide for Weight Loss in Jupiter, FL

What is tirzepatide?

Why obesity is difficult to treat

Obesity is a metabolic condition, not a willpower problem

How does tirzepatide work?

The SURMOUNT-1 Trial: A Deep Dive Into Tirzepatide for Weight-Loss

How the SURMOUNT-1 trial was designed

What the SURMOUNT-1 trial found

Health improvements beyond weight loss

What are the side effects of tirzepatide?

Where tirzepatide fits in obesity treatment

Who should not use tirzepatide or semaglutide?

How Much Does Tirzepatide Cost?

How do I get tirzepatide at NovaGenix?

Start with a consultation in Jupiter

Contact Us

Schedule a Consultation